Literature DB >> 8801059

Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases.

W Tang1, A G Borel, F S Abbott.   

Abstract

The hepatotoxic metabolite of the anticonvulsant drug valproic acid (VPA), namely (E)-2-propyl-2,4-pentadienoic acid (E)-2,4-diene VPA), is known to react with glutathione (GSH) in vivo. Although glutathione-S-transferase (GST) was suspected of being the catalyst for this conjugation reaction, this was yet to be confirmed. In this study, GST activities were detected in the hepatic cytosolic and sonic-disrupted mitoplast fractions isolated from male Sprague-Dawley rats by using 1-chloro-2,4-dinitrobenzene as a substrate. An elevation of GST activities by 45 to 100% was observed after pretreatment of rats with phenobarbital (PB). Subsequently, these apparent GST activities were examined for their effects on the in vivo conjugation of GSH with N-acetyl-S-((E)-2-propyl-2,4-pentadienoyl)cysteamine (2,4-diene VPA-NACA), a structural mimic of (E)-2,4-diene VPA coenzyme A thioester. Reaction products were identified and quantitated by combined liquid chromatography-tandem mass spectrometry. The GST-mediated conjugation of GSH with 2,4-diene VPA-NACA produced two structural isomers via either 5,6- or 1,6-addition of GSH. Only the 1,6- addition product was found for the spontaneous conjugation reaction (control). Quantitatively, GSH conjugates formed in the cytosolic fraction were 23-fold that of control. An additional 1.5-fold enhancement was observed in the cytosolic fraction from PB-treated rats. The production of the GSH conjugates was increased by 2-fold for reactions involving the sonic-disrupted mitoplasts, either from untreated or PB-treated rats. Partially purified GST was found to catalyze the conjugation reactions in a fashion similar to that of the isolated subcellular fractions. No reaction with GSH could be detected for the free acid form of (E)-2,4-diene VPA. As was the case with the in vitro data, two structural isomers of GSH conjugates were detected in the bile of rats that received (E)-2,4-diene VPA. These results indicate that in vivo production of the GSH conjugates of (E)-2,4-diene VPA is most likely catalyzed by GST enzymes, with the esterified diene being essential for the conjugation reaction. In a separate experiment, 2,4-diene VPA-NACA was observed to alkylate reduced oxytocin through one or both cysteine residues. Thus, the toxicity of (E)-2,4-diene VPA might be produced via either GST-promoted depletion of cellular GSH, or a direct modification of key proteins, or both.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801059

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  4 in total

1.  HNRNPR Variants that Impair Homeobox Gene Expression Drive Developmental Disorders in Humans.

Authors:  Floor A Duijkers; Andrew McDonald; Georges E Janssens; Marco Lezzerini; Aldo Jongejan; Silvana van Koningsbruggen; Wendela G Leeuwenburgh-Pronk; Marcin W Wlodarski; Sébastien Moutton; Frédéric Tran-Mau-Them; Christel Thauvin-Robinet; Laurence Faivre; Kristin G Monaghan; Thomas Smol; Odile Boute-Benejean; Roger L Ladda; Susan L Sell; Ange-Line Bruel; Riekelt H Houtkooper; Alyson W MacInnes
Journal:  Am J Hum Genet       Date:  2019-05-09       Impact factor: 11.025

2.  Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.

Authors:  Howard Horng; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

3.  Expressions of glutathione S-transferase alpha, mu, and pi in brains of medically intractable epileptic patients.

Authors:  Wei Shang; Wei-Hong Liu; Xiu-He Zhao; Qin-Jian Sun; Jian-Zhong Bi; Zhao-Fu Chi
Journal:  BMC Neurosci       Date:  2008-07-18       Impact factor: 3.288

4.  An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood-Brain Barrier in Epileptic Patients.

Authors:  Risa Sato; Kotaro Ohmori; Mina Umetsu; Masaki Takao; Mitsutoshi Tano; Gerald Grant; Brenda Porter; Anthony Bet; Tetsuya Terasaki; Yasuo Uchida
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.